Literature DB >> 1726699

Human B cell proliferative responses during aging. Reduced RNA synthesis and DNA replication after signal transduction by surface immunoglobulins compared to B cell antigenic determinants CD20 and CD40.

R L Whisler1, J W Williams, Y G Newhouse.   

Abstract

Age-related reductions in the DNA replication of human peripheral blood B cells have been reported after stimulation by cross-linking surface immunoglobulins (sIg) with the polyclonal activator Staphylococcus aureus Cowan I (SAC). However, little is known about the mechanisms of these age-related impairments. To examine whether these impairments represented defects unique to sIg mediated signalling, B cells from elderly humans were stimulated with SAC, immobilized anti-IgM and with monoclonal antibodies (mAbs) specific for B cell CD20 and CD40 determinants. Regardless of the stimuli or combinations of stimuli, the proliferative responses of B cells from elderly subjects remained 50% or less of the values observed for B cells from young subjects. Also, the failure to fully restore the age-related impairments of B cells could not be attributed to an absolute lack of potentially reactive cells. Supplementation of anti-IgM stimulated B cells from elderly subjects with IL-2, IL-4 or B cell growth factor (BCGF) revealed that BCGF was able to improve the reduced responses to levels approximating B cells of young subjects. The age-related defects were not restricted to B cell DNA replication because reductions in G1 progression of stimulated B cells from elderly subjects were directly demonstrated by decreased [3H]uridine incorporation into de novo RNA synthesis. However, the age-related impairments in RNA synthesis were less severe than those in DNA replication consistent with progressively greater reductions in the abilities of B cells to traverse the entire cell cycle. Other results showed that the reduced DNA replication of B cells from elderly subjects to immobilized anti-IgM with and without IL-2 did not represent a premature exit of B cells from DNA replication and accelerated maturation into antibody producing cells. Thus, these studies demonstrate that age-related impairments exist in activation signals mediated by several types of human B cell determinants and that abnormalities can be detected during pre-S phase events.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726699     DOI: 10.1016/0047-6374(91)90018-u

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  7 in total

1.  Age-dependent altered proportions in subpopulations of tonsillar lymphocytes.

Authors:  W Bergler; S Adam; H J Gross; K Hörmann; R Schwartz-Albiez
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

Review 3.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

4.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

5.  Aged B lymphocytes retain their ability to express surface markers but are dysfunctional in their proliferative capability during early activation events.

Authors:  Anthony Blaeser; Kiley McGlauchlen; Laura A Vogel
Journal:  Immun Ageing       Date:  2008-11-17       Impact factor: 6.400

Review 6.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

7.  Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice.

Authors:  T Zhou; C K Edwards; J D Mountz
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.